Literature DB >> 6487508

Cardiovascular and biochemical responses to nebulised salbutamol in normal subjects.

S R Smith, C Ryder, M J Kendall, R Holder.   

Abstract

When conventional therapeutic doses of nebulised salbutamol were given to normal volunteers, there was a significant rise in pulse rate, systolic blood pressure and plasma glucose and a significant fall in diastolic blood pressure and serum potassium in comparison with placebo. Such changes may be potentially hazardous in certain situations. Patients with airways obstruction due to chronic bronchitis who have coexistent ischaemic heart disease or diuretic induced hypokalaemia may be at particular risk from the unwanted cardiovascular and biochemical responses to nebulised salbutamol.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6487508      PMCID: PMC1463610          DOI: 10.1111/j.1365-2125.1984.tb02520.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  8 in total

1.  Metabolic effects of salbutamol: comparison of aerosol and intravenous administration.

Authors:  A Neville; J B Palmer; J Gaddie; C S May; K N Palmer; L E Murchison
Journal:  Br Med J       Date:  1977-02-12

2.  The metabolic effects of inhaled salbutamol.

Authors:  S M Bateman; J Pidgeon; S G Spiro; A J Johnson
Journal:  Br J Clin Pharmacol       Date:  1978-02       Impact factor: 4.335

3.  Systemic effects of inhalation of terbutaline with IPPB in normal subjects.

Authors:  B G Simonsson; H Svedenblad; I Axelsson; A L Andersson
Journal:  Scand J Respir Dis       Date:  1974

4.  Nebulised salbutamol and angina.

Authors:  E Neville; P A Corris; J Vivian; S Nariman; G J Gibson
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-18

5.  Comparison of inhaled and intravenous terbutaline in acute severe asthma.

Authors:  S J Williams; S J Winner; T J Clark
Journal:  Thorax       Date:  1981-08       Impact factor: 9.139

6.  Cardiovascular and metabolic effects of terbutaline.

Authors:  M J Kendall; S Dean; D Bradley; R Gibson; D J Worthington
Journal:  J Clin Hosp Pharm       Date:  1982-03

7.  Diuretic-induced ventricular ectopic activity.

Authors:  O B Holland; J V Nixon; L Kuhnert
Journal:  Am J Med       Date:  1981-04       Impact factor: 4.965

8.  Optimal dose of salbutamol respiratory solution: comparison of three doses with plasma levels.

Authors:  E H Walters; A Cockroft; T Griffiths; K Rocchiccioli; B H Davies
Journal:  Thorax       Date:  1981-08       Impact factor: 9.139

  8 in total
  14 in total

Review 1.  Nebulisers for the elderly.

Authors:  J C Pounsford
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

2.  Serum potassium responses to nebulized salbutamol administered during an acute asthmatic attack.

Authors:  D DaCruz; C Holburn
Journal:  Arch Emerg Med       Date:  1989-03

3.  Modulation of the effects of salbutamol by propranolol and atenolol.

Authors:  N A Minton; A R Baird; J A Henry
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

4.  Potentiation of the adverse effects of intravenous terbutaline by oral theophylline.

Authors:  S R Smith; M J Kendall
Journal:  Br J Clin Pharmacol       Date:  1986-04       Impact factor: 4.335

5.  The effect of salbutamol on performance in endurance cyclists.

Authors:  S R Norris; S R Petersen; R L Jones
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

Review 6.  Salbutamol in the 1980s. A reappraisal of its clinical efficacy.

Authors:  A H Price; S P Clissold
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

7.  The effects of ketotifen on beta-adrenergic activity in asthmatics.

Authors:  R I Gove; P S Burge; D E Stableforth; C Skinner
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

8.  Effect of nebulised salbutamol on maximal exercise performance in men with mild asthma.

Authors:  W Freeman; G E Packe; R M Cayton
Journal:  Thorax       Date:  1989-11       Impact factor: 9.139

9.  Treatment of hyperkalaemia using intravenous and nebulised salbutamol.

Authors:  R J McClure; V K Prasad; J T Brocklebank
Journal:  Arch Dis Child       Date:  1994-02       Impact factor: 3.791

10.  The dose-related hyper-and-hypokalaemic effects of salbutamol and its arrhythmogenic potential.

Authors:  W J Du Plooy; L Hay; C P Kahler; P J Schutte; H D Brandt
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.